Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Consulting Firm
|
gptkbp:collaboratesWith |
Research Institutions
Healthcare Organizations |
gptkbp:focusesOn |
Biotechnology
Medical Devices Pharmaceuticals |
gptkbp:hasAwards |
Innovation Awards
Industry Recognition Awards Consulting Excellence Awards |
gptkbp:hasClient |
Medical Device Manufacturers
Global_Pharmaceutical_Companies Biotech_Firms |
gptkbp:hasEmployees |
Over 300,000
|
gptkbp:hasHistoricalSignificance |
gptkb:Paris,_France
|
gptkbp:hasParticipatedIn |
Over 40 countries
|
gptkbp:hasPartnershipsWith |
Academic Institutions
Technology Providers |
gptkbp:hasResidence |
€18 billion (2020)
|
gptkbp:hasSocialMediaPresence |
Facebook
|
gptkbp:hasWebsite |
www.capgemini.com
|
https://www.w3.org/2000/01/rdf-schema#label |
Capgemini Life Sciences
|
gptkbp:isHeadquarteredIn |
gptkb:Paris
|
gptkbp:isInvolvedIn |
Clinical Trials
Market Research Patient Safety Health Technology Assessment Data_Management |
gptkbp:isKnownFor |
Industry Expertise
Client-Centric_Approach Innovative_Solutions |
gptkbp:isPartOf |
gptkb:Capgemini_SE
|
gptkbp:offers |
Patient Engagement Solutions
Consulting_Services Supply_Chain_Management_Solutions Quality_Assurance_Services Regulatory_Affairs_Services Market_Access_Solutions Pharmacovigilance_Services |
gptkbp:operatesIn |
Life_Sciences_Sector
|
gptkbp:partOf |
gptkb:Capgemini_Group
|
gptkbp:provides |
Regulatory_Compliance_Services
Digital_Transformation_Solutions Clinical_Development_Services |
gptkbp:utilizes |
Artificial Intelligence
Cloud Computing Data_Analytics |
gptkbp:wasFoundedIn |
1967
|